CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 207 enrolled
Drug / intervention
Polyethylene Glycol, 0.4%, Propylene Glycol, 0.3% eye dropsother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02380248
NCT02380248N/ACompleted
CompareCT.gov

Clinical Evaluation of Systane® Gel Drops on Corneal Staining in Indian Subjects With Dry Eye

Alcon Research·interventional·Posted Mar 5, 2015·Updated Jul 2, 2018

In Brief

A clinical study evaluating Polyethylene Glycol, 0.4%, Propylene Glycol, 0.3% eye drops for Dry Eye. Completed, enrolled 207 participants across 1 site.

Detailed Summary

The purpose of this study is to evaluate the efficacy and safety of Systane® Gel Drops in dry eye subjects following 90 days of QID (4 times/day) dosing.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDry Eye
CountriesIndia
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedMar 5, 2015
Enrollment StartMay 14, 2015
Primary CompletionJun 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1.0 yearsPosted 11.3 years ago

Interventions

Polyethylene Glycol, 0.4%, Propylene Glycol, 0.3% eye dropsother